DelfaGLP-1 Atlas

Lead sponsor

Texas Tech University

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

1

Active

173

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Not applicable
2

Trials by status

Recruiting
1
Completed
1

Trials led

Study of Patients Being Treated With Anti-obesity MedicationBMI ≥30not applicableRecruiting100
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue ReactivityBMI 30-50not applicableCompleted73